RLFTF
Relief Therapeutics Holding AG

4,770
Mkt Cap
$30.24M
Volume
2,350.00
52W High
$4.93
52W Low
$1.40
PE Ratio
-1.54
RLFTF Fundamentals
Price
$2.40
Prev Close
$1.55
Open
$2.24
50D MA
$3.57
Beta
0.39
Avg. Volume
1,832.37
EPS (Annual)
-$1.55
P/B
0.74
Rev/Employee
$308,307.16
Loading...
Loading...
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
31

Frequently Asked Questions

What is Market Cap of MindMaze Therapeutics Holding SA?
What is the 52-week high for MindMaze Therapeutics Holding SA?
What is the 52-week low for MindMaze Therapeutics Holding SA?
What is MindMaze Therapeutics Holding SA stock price today?
What was MindMaze Therapeutics Holding SA stock price yesterday?
What is the PE ratio of MindMaze Therapeutics Holding SA?
What is the Price-to-Book ratio of MindMaze Therapeutics Holding SA?
What is the 50-day moving average of MindMaze Therapeutics Holding SA?
How many employess does MindMaze Therapeutics Holding SA has?

Latest RLFTF News

View
No RLFTF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.